Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Zhengye Biotechnology Holding OCF Margin %?
Zhengye Biotechnology HoldingZYBT -2.05%20 OCF Margin % is 50.52% as of Dec. 2025, which is 240% above its 10-year median of 14.86. GuruFocus rates ZYBT with a GF Score™ of 20/100. The stock has 5 warning signs investors should review. Among 960 Drug Manufacturers companies, Zhengye Biotechnology Holding ranks better than 57.29% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zhengye Biotechnology Holding's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhengye Biotechnology Holding OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhengye Biotechnology Holding's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Zhengye Biotechnology Holding's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhengye Biotechnology Holding (ZYBT) has a OCF Margin % of 50.52% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Zhengye Biotechnology Holding and its competitors. This is 240% above median its historical median of 14.86. Over the past decade, Zhengye Biotechnology Holding's OCF Margin % has ranged from 6.66 to 22.76. According to the industry distribution chart, Zhengye Biotechnology Holding ranks #410 out of 960 companies in the Drug Manufacturers industry, placing it in the top 42.7%.
Is Zhengye Biotechnology Holding's OCF Margin % too high?
Zhengye Biotechnology Holding's current OCF Margin % of 50.52% is 240% above median its 10-year median of 14.86. Over the past 10 years, this metric has ranged from a low of 6.66 to a high of 22.76. The Drug Manufacturers industry median OCF Margin % is 9.75. Zhengye Biotechnology Holding's value of 50.52% is 418.2% above this industry median. Based on the distribution chart, Zhengye Biotechnology Holding ranks #410 out of 960 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Zhengye Biotechnology Holding has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Zhengye Biotechnology Holding's OCF Margin % compare to TLPH and CPHI?
According to the Drug Manufacturers industry distribution chart, Zhengye Biotechnology Holding ranks #410 out of 960 companies for OCF Margin %. This puts Zhengye Biotechnology Holding in the upper half of its industry. The industry median OCF Margin % is 9.75. Zhengye Biotechnology Holding's value of 50.52% is 418.2% above this benchmark. Historically, Zhengye Biotechnology Holding's own OCF Margin % has ranged from 6.66 to 22.76 over the past decade. While the company's 10-year median is 14.86 vs. the industry median of 9.75, Zhengye Biotechnology Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.75, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhengye Biotechnology Holding's current OCF Margin % of 50.52% is 418.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Zhengye Biotechnology Holding and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhengye Biotechnology Holding's current OCF Margin % is 50.52%, which is 240% above median its own 10-year median of 14.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhengye Biotechnology Holding stock overvalued right now?
Zhengye Biotechnology Holding (ZYBT) has a current OCF Margin % of 50.52%. The current OCF Margin % is 50.52%, which is 240% above median its 10-year median of 14.86 and 418.2% above the Drug Manufacturers industry median of 9.75. Zhengye Biotechnology Holding's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Zhengye Biotechnology Holding (ZYBT), the current OCF Margin % is 50.52% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
20GF Score
Get the complete analysis for ZYBT
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZYBT has been successfully added to your 
